Loading…
Based on limited metadata, the FDA issued a warning letter to Degasa S.A. De C.V. on April 18, 2018, regarding a product categorized as "Other." Without access to the full warning letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The issuing office is not specified in this metadata, which limits clarity on the specific regulatory division and product category involved. To understand the particular compliance issues and required corrective actions, review of the complete warning letter would be necessary.